The levels of expression of galectin-1, galectin-3, and the Thomsen-Friedenreich antigen and their binding sites decrease as clinical aggressiveness increases in head and neck cancers.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples